BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 38138293)

  • 21. Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.
    Han BH; Vellimana AK; Zhou ML; Milner E; Zipfel GJ
    Neurosurgery; 2012 Jan; 70(1):178-86; discussion 186-7. PubMed ID: 21796010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.
    Farrow KN; Lee KJ; Perez M; Schriewer JM; Wedgwood S; Lakshminrusimha S; Smith CL; Steinhorn RH; Schumacker PT
    Antioxid Redox Signal; 2012 Aug; 17(3):460-70. PubMed ID: 22229392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
    Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
    Ballard SA; Gingell CJ; Tang K; Turner LA; Price ME; Naylor AM
    J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Cyclic GMP Export by Multidrug Resistance Protein 4: A New Strategy to Treat Erectile Dysfunction?
    Boydens C; Pauwels B; Vanden Daele L; Van de Voorde J
    J Sex Med; 2017 Apr; 14(4):502-509. PubMed ID: 28258955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overall cardiovascular profile of sildenafil citrate.
    Zusman RM; Morales A; Glasser DB; Osterloh IH
    Am J Cardiol; 1999 Mar; 83(5A):35C-44C. PubMed ID: 10078541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
    Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil's impact on male infertility: what has changed in 20 years?
    Scherzer ND; Le TV; Hellstrom WJG
    Int J Impot Res; 2019 Mar; 31(2):71-73. PubMed ID: 30837720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDE5 inhibitor efficacy is estrogen dependent in female heart disease.
    Sasaki H; Nagayama T; Blanton RM; Seo K; Zhang M; Zhu G; Lee DI; Bedja D; Hsu S; Tsukamoto O; Takashima S; Kitakaze M; Mendelsohn ME; Karas RH; Kass DA; Takimoto E
    J Clin Invest; 2014 Jun; 124(6):2464-71. PubMed ID: 24837433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.
    Kruuse C; Khurana TS; Rybalkin SD; Birk S; Engel U; Edvinsson L; Olesen J
    Eur J Pharmacol; 2005 Oct; 521(1-3):105-14. PubMed ID: 16182282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Pharmacol Rep; 2012; 64(5):1259-66. PubMed ID: 23238482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of phosphodiesterase Type 5 enhances rat neurohypophysial excitability and electrically evoked oxytocin release.
    Zhang Z; Klyachko V; Jackson MB
    J Physiol; 2007 Oct; 584(Pt 1):137-47. PubMed ID: 17690141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line.
    Limoncella S; Lazzaretti C; Paradiso E; D'Alessandro S; Barbagallo F; Pacifico S; Guerrini R; Tagliavini S; Trenti T; Santi D; Simoni M; Sola M; Di Rocco G; Casarini L
    Mol Cell Endocrinol; 2022 Feb; 542():111527. PubMed ID: 34875337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients.
    Kniotek M; Boguska A
    J Immunol Res; 2017; 2017():4541958. PubMed ID: 28316997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
    Houslay MD
    Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
    Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing of sildenafil as antitumour; induction of cyclic guanosine monophosphate/protein kinase G pathway, caspase-dependent apoptosis and pivotal reduction of Nuclear factor kappa light chain enhancer of activated B cells in lung cancer.
    AboYoussef AM; Khalaf MM; Malak MN; Hamzawy MA
    J Pharm Pharmacol; 2021 Jul; 73(8):1080-1091. PubMed ID: 33856030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.